Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions

American Journal of Pathology

Volumn 154, Issue 1, 1999, Pages 45-51

  Van Der Voorn, Patrick ^a   Tekstra, Janneke ^a   Beelen, Rob H J ^a   Tensen, Cornelis P ^a   Van Der Valk, Paul ^a   De Groot, Corline J A ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN;

ARTICLE; ASTROCYTE; BRAIN TISSUE; CELLULAR DISTRIBUTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0032920496     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65249-2     Document Type: Article

References (26)

1. McDonald WI, Miller DH, Barnes D: The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992, 18:319-334
2. Constant CF: The pathogenesis of multiple sclerosis. Lancet 1994, 343:271-275
3. Lassmann H: Basic mechanisms of brain inflammation. J Neural Transm 1997, 50:183-190
4. Ruuls SR, Bauer J, Sontrop K, Huitinga I, 't Hart BA, Dijkstra CD: Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 1995, 56:207-217
5. De Groot CJA, Ruuls SR, Theeuwes JWM, Dijkstra CD, Van Der Valk P: Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 1997, 56:10-20
6. Bauer J, Sminia T, Wouterlood FG, Dijkstra CD: Phagocytic activity of macrophages ard microglial cells during acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neurosci Res 1994, 38:365-375
7. Brück W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, Lassmann H: Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995, 38:788-796
8. Huitinga I, Van Rooijen N, De Groot CJA, Uitdehaag B, Dijkstra CD: Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990, 172:1025-1033
9. Huitinga I, Ruuls SR, Jung S, Van Rooijen N, Hartung HP, Dijkstra CD: Macrophages in T cell line-mediated, cemyelinating, and chronic relapsing experimental allergic encephalomyelitis in Lewis rats. Clin Exp Immunol 1995, 100:344-351
10. Tani M, Ransohoff RM: Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma? Brain Pathol 1994, 4:135-143
11. Furie MB, Randolph GJ: Chemokines and tissue injury. Am J Pathol 1995, 146:1287-1301
12. Baggiolini M, Dewald B, Moser B: Human chemokines: an update. Annu Rev Immunol 1997, 15:675-705
13. Takeya M: Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993, 24:534-539
14. Strieter RM, Koch AE, Antony VB, Fick RB Jr, Strandiford TJ, Kunkel SL: The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. J Lab Clin Med 1994, 123:183-197
15. Cai JP, Hudson S, Ye MW, Chin YH: The intracellular signalling pathways involved in MCP-1-stimulated T cell migration across microvascular endothelium. Cell Immunol 1996, 167:269-275
16. Myagishi R, Kikuchi S, Fukazawa T, Tashiro K. Macrophage inflammatory protein-1α in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. Neurol Sci 1995, 129:223-227
17. Peri G, Milanese C, Matteucci C, Ruco L, Zhou D, Sozzani S, Coletta I. Mantovani A: A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines: development of a sandwich ELISA and in situ detection of producing cells. J Immunol Methods 1994, 174:249-257
18. Bö L, Mork S, Kong PA, Nyland H, Pardo CA, Trapp BD: Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994, 51:135-146
19. Lassmann H: Comparative Neuropathology of Chronic Experimental Encephalomyelitis and Multiple Sclerosis. Berlin, Springer-Verlag, 1983
20. Myagishi R, Kikuchi S, Takayama C, Inoue Y, Tashiro K: Identification of cell types producing RANTES, MIP-1α and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridization. J Neuroimmunol 1997, 77:17-26
21. Godiska R, Chantry D, Dietsch GN, Gray PW: Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 1995, 58:167-176
22. Hohlfeld R: Biotechnological agents for the immunotherapy of multiple sclerosis. Brain 1997, 120:865-916
23. Taub D, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ: Chemokines and T lymphocyte activation. β-chemokines co-stimulate human T lymphocyte activation. J Immunol 1996, 156:2095-3000
24. Johnatty RN, Taub DD, Reeder SP, Turcovski-Corrales SM, Cottam DW, Stephenson TJ, Rees RC: Cytokine and chemokine regulation of pro-MMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997, 158:2327-2333
25. Cossins J, Clements J, Ford J, Miller KM, Pigott R, Vos W, Van Der Valk P, De Groot CJA: Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol 1997, 94: 590-598
26. Stüve O, Chabot S, Jung SS, Williams G, Yong VW: Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9. J Neuroimmunol 1997, 80:38-46